Results: Elevated sPD-L1 levels were observed in several tumor types, including ovarian cancer, renal cell carcinoma, and gastric cancer, where they were associated with features of advanced disease, such as tumor size, stage, and metastases. The gene discussed is SPDL1; the disease is hereditary clear cell renal cell carcinoma.